Arrowhead Research Corporation (ARWR) Stock Price

ARWRStock
$88.88+306.61%52W
Market Cap$12.55B
P/E
PEG Ratio
Div yield
Beta1.27

ARWR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)23.47%
Price vs S&P 500 (4W)-1.94%
VGM Score58.48

ARWR Earnings Surprise History

Q2 25-1.26est. -1.10
Q3 25-0.18est. -0.16
Q4 250.22est. -0.37
Q1 26-0.93est. -1.11
Q2 26-1.36est. -1.23

ARWR Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.05
4.05
4.05
4.25

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
ARWRArrowhead Research Corporation
DAB$88.88
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Arrowhead Research Corporation

Arrowhead Pharmaceuticals is a biotechnology company developing genetic medicines to treat diseases caused by protein overproduction. Its pipeline spans cardiovascular, cardiometabolic, pulmonary, central nervous system, liver, muscular, and complement-mediated disease areas, with the majority of its product candidates concentrated in liver disease treatments.